Back to
MAI Capital Management
CYCN7 quarters
Position history for
MAI Capital Management's holdings in CYCLERION THERAPEUTICS INC
No. MAI Capital Management exited its CYCN (Cyclerion Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 100 shares worth $155. MAI Capital Management first reported CYCN in Q4 2024 and held it in 6 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$322
Total Shares Change
-100
Quarter-by-Quarter History
Other major holders of CYCN: FMR LLC, BALYASNY ASSET MANAGEMENT L.P.